Загрузка...
Lipoprotein effects of incretin analogs and dipeptidyl peptidase 4 inhibitors
Elevated post-prandial lipoprotein levels are common in patients with type 2 diabetes. Post-prandial lipoprotein alterations in type 2 diabetics are widely believed to drive inflammation and are considered a major risk factor for cardiovascular disease in diabetic patients. The incretins glucagon li...
Сохранить в:
| Опубликовано в: : | Clin Lipidol |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4437760/ https://ncbi.nlm.nih.gov/pubmed/26005496 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/clp.14.59 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|